Live Breaking News & Updates on Intellipharmaceutics International

Stay updated with breaking news from Intellipharmaceutics international. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Intellipharmaceutics Announces Downgrade to OTC Expert Market

TORONTO, ON / ACCESSWIRE / June 14, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI.H) ("Intellipharmaceutics" or the "Company"), announced today that its common stock, currently traded on the OTCQB market, is expected to be downgraded to the OTC Expert Market on June 1. ....

United States , Isa Odidi , Company Contact , Regulation Services Provider , Ontario Securities Commission On , Venture Exchange , Intellipharmaceutics International Inc , Intellipharmaceutics International , Expert Market , Best Execution , Limit Orders , Ontario Securities Commission , Point Of Divergence Drug Delivery System , Securities Act ,

Super Generics Market Size Will Reach USD 128.62 Billion to 2031 - Revealed InsightAce Latest Study

/PRNewswire/ InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Super Generics Market –By Therapeutic Area. ....

South Africa , United Kingdom , United States , South Korea , Kashiv Biosciences , Asia Pacific , Teva Treanda , Mayne Pharma , Tesa Labtec , Latitude Pharmaceuticals , Route Of Administration Intravenous , Teva Pharmaceutical , Azurity Pharmaceuticals , Exela Pharma Sciences , Route Of Administration , Accord Healthcare Inc , Harrow Health , Hikma Pharmaceuticals , Rubicon Research , Ascendia Pharmaceuticals , Taiwan Liposome Company , Intellipharmaceutics International , Ace Analytic , Super Generics Market , Therapeutic Area , Cardiovascular Disorders ,

Intellipharmaceutics International Inc. Announces Transfer of Listing to NEX and New Stock Option Plan

Intellipharmaceutics International Inc. Announces Transfer of Listing to NEX and New Stock Option Plan
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Isa Odidi , Regulation Services Provider , Intellipharmaceutics International Inc , Ontario Securities Commission , Company Manual , Venture Exchange , Company Contact , Intellipharmaceutics International , Cease Trade Order , Company The , Point Of Divergence Drug Delivery System , Securities Act ,

Intellipharmaceutics International Inc.: Intellipharmaceutics Announces Its Expected Delay in Filing Annual Audited Financial Statements and Annual Information Form

Intellipharmaceutics International Inc.: Intellipharmaceutics Announces Its Expected Delay in Filing Annual Audited Financial Statements and Annual Information Form
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Isa Odidi , Company Contact , Ontario Securities Commission , Intellipharmaceutics International Inc , Intellipharmaceutics International , Chief Executive Officer , Chief Financial Officer , Required Filings , Filing Deadline , Multilateral Instrument , File Cease Trade Orders , Multiple Jurisdictions , Point Of Divergence Drug Delivery System , Securities Act ,